Paying users zone. Data is hidden behind hidden .

Get 1-month access to Abbott Laboratories for $19.99, or
get full access to the entire website for at least 3 months from $49.99.

We accept:

Unlock

This is a one-time payment. There is no automatic renewal.

Abbott Laboratories (ABT)

Analysis of Property, Plant and Equipment

Advanced level

Accounting Policy on Property, Plant and Equipment
Property, Plant and Equipment Disclosure
Asset Age Ratios (Summary)
Average Age
Estimated Total Useful Life
Estimated Age, Time Elapsed Since Purchase
Estimated Remaining Life

Accounting Policy on Property, Plant and Equipment

Depreciation and amortization are provided on a straight-line basis over the estimated useful lives of the assets. The following table shows estimated useful lives of property and equipment:

Classification	Estimated Useful Lives
Buildings	10 to 50 years (average 27 years)
Equipment	to 20 years (average 11 years)

Source: 10-K (filing date: 2019-02-22).

Property, Plant and Equipment Disclosure

Abbott Laboratories, balance sheet: property, plant and equipment

US$ in millions

		Dec 31, 2018		Dec 31, 2017		Dec 31, 2016		Dec 31, 2015		Dec 31, 2014
	Land
	Buildings
	Equipment
	Construction in progress
	Property and equipment, at cost
	Accumulated depreciation and amortization
	Net property and equipment

Based on: 10-K (filing date: 2019-02-22), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-27).

Item	Description	The company
Property and equipment, at cost	Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.	Abbott Laboratories’s property and equipment, at cost increased from 2016 to 2017 and from 2017 to 2018.
Net property and equipment	Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.	Abbott Laboratories’s net property and equipment increased from 2016 to 2017 but then slightly decreased from 2017 to 2018.

Asset Age Ratios (Summary)

Abbott Laboratories, asset age ratios

		Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
	Average age ratio
	Estimated total useful life (years)
	Estimated age, time elapsed since purchase (years)
	Estimated remaining life (years)

Based on: 10-K (filing date: 2019-02-22), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-27).

Asset age ratio	Description	The company
Average age ratio	As long as straight-line depreciation is used, this is an accurate estimate of asset age as a percentage of depreciable life. The relative age is a useful measure of whether the company’s fixed asset base is old or new. Newer assets are likely to be more efficient.	Abbott Laboratories’s average age ratio of depreciable property, plant and equipment improved from 2016 to 2017 but then slightly deteriorated from 2017 to 2018.
Estimated total useful life	Over longer time periods, this ratio is a useful measure of company’s depreciation policy and can be used for comparisons with competitors.	Abbott Laboratories’s estimated total useful life of depreciable property, plant and equipment decreased from 2016 to 2017 and from 2017 to 2018.
Estimated time elapsed since purchase	The approximate age in years of a company’s fixed assets. Useful for comparison purposes.	Abbott Laboratories’s estimated time elapsed since purchase of depreciable property, plant and equipment improved from 2016 to 2017 but then slightly deteriorated from 2017 to 2018.
Estimated remaining life		Abbott Laboratories’s estimated remaining life of depreciable property, plant and equipment increased from 2016 to 2017 but then decreased significantly from 2017 to 2018.

Average Age

		Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
	Selected Financial Data (US$ in millions)
	Accumulated depreciation and amortization
	Property and equipment, at cost
	Land
	Asset Age Ratio
	Average age¹

Based on: 10-K (filing date: 2019-02-22), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-27).

2018 Calculations

¹ Average age = 100 × Accumulated depreciation and amortization ÷ (Property and equipment, at cost – Land)
= 100 × hidden ÷ ( hidden – hidden ) = hidden

Asset age ratio	Description	The company
Average age	As long as straight-line depreciation is used, this is an accurate estimate of asset age as a percentage of depreciable life. The relative age is a useful measure of whether the company’s fixed asset base is old or new. Newer assets are likely to be more efficient.	Abbott Laboratories’s average age ratio of depreciable property, plant and equipment improved from 2016 to 2017 but then slightly deteriorated from 2017 to 2018.

Estimated Total Useful Life

		Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
	Selected Financial Data (US$ in millions)
	Property and equipment, at cost
	Land
	Depreciation expense
	Asset Age Ratio (Years)
	Estimated total useful life¹

Based on: 10-K (filing date: 2019-02-22), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-27).

2018 Calculations

¹ Estimated total useful life = (Property and equipment, at cost – Land) ÷ Depreciation expense
= ( hidden – hidden ) ÷ hidden = hidden

Asset age ratio	Description	The company
Estimated total useful life	Over longer time periods, this ratio is a useful measure of company’s depreciation policy and can be used for comparisons with competitors.	Abbott Laboratories’s estimated total useful life of depreciable property, plant and equipment decreased from 2016 to 2017 and from 2017 to 2018.

Estimated Age, Time Elapsed since Purchase

		Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
	Selected Financial Data (US$ in millions)
	Accumulated depreciation and amortization
	Depreciation expense
	Asset Age Ratio (Years)
	Time elapsed since purchase¹

Based on: 10-K (filing date: 2019-02-22), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-27).

2018 Calculations

¹ Time elapsed since purchase = Accumulated depreciation and amortization ÷ Depreciation expense
= hidden ÷ hidden = hidden

Asset age ratio	Description	The company
Estimated time elapsed since purchase	The approximate age in years of a company’s fixed assets. Useful for comparison purposes.	Abbott Laboratories’s estimated time elapsed since purchase of depreciable property, plant and equipment improved from 2016 to 2017 but then slightly deteriorated from 2017 to 2018.

Estimated Remaining Life

		Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
	Selected Financial Data (US$ in millions)
	Net property and equipment
	Land
	Depreciation expense
	Asset Age Ratio (Years)
	Estimated remaining life¹

Based on: 10-K (filing date: 2019-02-22), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-27).

2018 Calculations

¹ Estimated remaining life = (Net property and equipment – Land) ÷ Depreciation expense
= ( hidden – hidden ) ÷ hidden = hidden

Asset age ratio	Description	The company
Estimated remaining life		Abbott Laboratories’s estimated remaining life of depreciable property, plant and equipment increased from 2016 to 2017 but then decreased significantly from 2017 to 2018.

	Abbott Laboratories	Other companies (not purchased previously)
Financial Statements
Common-Size Financial Statements
Analysis of Financial Ratios
Relative Valuation
Discounted Cash Flow (DCF) Valuation
Economic Value Added (EVA)
Long-term Trends
Analysis of Components of Financial Statements
Financial Reporting Quality

	All companies
Financial Statements
Common-Size Financial Statements
Analysis of Financial Ratios
Relative Valuation
Discounted Cash Flow (DCF) Valuation
Economic Value Added (EVA)
Long-term Trends
Analysis of Components of Financial Statements
Financial Reporting Quality